ClinicalTrials.gg
CompletedNCT06137846Updated Oct 22, 2026Results posted

Treatment of Peri-implant Mucositis and Supportive Peri-implant Therapy

An interventional study of Air-Polish and Ultrasonic in Peri-implant Mucositis, sponsored by University of Michigan. Completed at 1 site in United States. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by University of Michigan · Not applicable, Interventional, and Treatment

How we know

Updated Oct 22, 2026Results postedStudy documents posted+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
51
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 75 studies in Mucositis with a site in United States — 3 open to participants now, 4 under way, none of them phase 3. Mucositis · United States.

Enrollment
24th of 68
51 · median 33
Started
2023
with 1 other
No phase
20 of 75
2 open now
Registered
72nd of 75
by date

Among the 75 studies in Mucositis with a site in United States, this one is the 24th largest by enrollment of the 68 interventional ones that give a count, is one of 2 that started in 2023, is one of 20 with no phase, and was the 72nd registered.

Mucositis

265 studies on the registry are indexed under Mucositis; 34 are open to participants now.

Browse Mucositis studies →

Open to participants now

3 of the 75 studies in Mucositis with a site in United States are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 21 Mucositis studies recruiting now, 13 (62%) set no upper age limit and 7 (33%) stop at 75 or younger; 1 takes children under 18; 4 take healthy volunteers.

This study: 18 Years to 85 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 75 studies in Mucositis with a site in United States, or all of them as a file.
02

Study summary

The investigators are evaluating the therapeutic outcomes of two cleaning instruments on treating peri-implant mucositis. Peri-implant mucositis is inflammation around an implant that is limited to only the gum tissue and is characterized by bleeding on probing, pus, and without any evidence of bone loss. The investigators wish to compare the amount of inflammation and bacteria through measurements (like probing depth) and by collecting fluid and plaque samples around participants' implant after using one of the two cleaning instruments.

Read the detailed description

Despite the potential benefits of an air-polishing device with erythritol powder, clinical trials using the device as a monotherapy for treating patients with peri-implant mucositis remained limited. Therefore, the primary aim of the present study is to compare clinical outcomes of the non-surgical treatment of peri-implant mucositis and subsequent supportive peri-implant therapy (SPIT) using an erythritol air-polishing device or conventional mechanical debridement. The secondary aim is to compare the resolution of inflammation after non-surgical treatment of peri-implant mucositis and to monitor levels of peri-implant tissues inflammation during supportive peri-implant therapy by using the level of selected pro-inflammatory cytokines.

Up to 60 participants with dental implants will be recruited from patients seeking and/or receiving dental care at the University of Michigan Graduate Periodontics department, until 34 peri-mucositis participants and 17 healthy participants are achieved.

03

Conditions studied

  • Peri-implant Mucositis

Browse trials for

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 18 to 85 years.
  2. Healthy systemic conditions ( classification (ASA) I or II: systemically healthy or suffer from mild to moderate, but well controlled systemic diseases).
  3. Must have at least one osseointegrated dental implant with the following conditions (Berglundh et al. 2018a).

    • At least 12 months since the prosthesis was placed.
    • Absence of bone loss beyond crestal bone level changes from initial bone remodeling.
    • For implant mucositis subjects: Presence of bleeding and/or suppuration on gentle probing around implant at least 2 sites. Visual inspection demonstrating the presence of peri-implant signs of inflammation.
    • For healthy implant subjects: Absence of bleeding and/or suppuration on gentle probing around implant.
  4. Have a current (less than 6 months old) x-ray of the affected site
  5. All participants must be enrolled in a 3 to 6 months maintenance recall program including teeth/implants prophylaxis and supportive periodontal therapy.

Exclusion criteria

Exclusion criteria:

  1. Poorly controlled diabetes mellitus ( >6.5).
  2. Uncontrolled systemic disease or condition known to alter bone metabolism. (e.g. osteoporosis, osteopenia, hyperparathyroidism, Paget's disease)
  3. Current smokers or vapers.
  4. Pregnancy or could be pregnant (self-reported), or plan to be pregnant in the next 6 months.
  5. Long-term (3 months) intake of anti-inflammatory medications (e.g. non-steroidal anti-inflammatory drugs (NSAIDs)) known to affect periodontal status within one month previous to participation in the study.
  6. Taking .
  7. Long-term antibiotic use (> one weeks) within three months previous to participation in the study.
  8. No history of supragingival scaling or non-surgical therapy at the affected implant site in the last 1 month.
  9. Taking anticoagulant medications.
  10. Subjects who require prophylactic antibiotics.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
51 participants (actual)

Study arms

  • Experimental
    Peri-mucositis

    Dental implant has peri-implant mucositis

    Device: Air-Polish · Device: Ultrasonic

  • Placebo comparator
    Healthy

    Dental implant does not have peri-implant mucositis

    Device: Air-Polish

Interventions

  • DeviceAir-Polish

    Dental implant will be cleaned with an airpolishing device

  • DeviceUltrasonic

    Dental implant will be cleaned with an ultrasonic device with a plastic tip

06

What researchers measure

Primary outcomes

  1. Probing Depth Measurements

    To compare probing depth measurements in millimeters after non-surgical treatment of peri-implant mucositis

    Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months

  2. Bleeding on Probing Scores (Mombelli et al.)

    To compare bleeding on probing after non-surgical treatment of peri-implant mucositis. Possible scores range from 0 to 3, with higher scores indicating heavier bleeding.

    Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months

  3. Plaque Score (Loe & Silness)

    To compare plaque scores after non-surgical treatment of peri-implant mucositis. Possible scores range from 0 to 3, with higher scores indicating greater plaque accumulation.

    Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months

  4. Gingival Index (Loe & Silness)

    To compare gingival index scores after non-surgical treatment of peri-implant mucositis. Possible scores range from 0 to 3, with higher scores indicating greater inflammation.

    Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months

  5. Gum Recession Measurement

    To compare gum recession after non-surgical treatment of peri-implant mucositis

    Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months

  6. Bone Measurement

    Loss of supporting bone measured by standardized radiographs

    Time frame: Baseline, 3 months, and 6 months

Secondary outcomes

  1. Interleukin-6 Levels

    To compare changes in the concentration of interleukin-6 (IL-6) in peri-implant crevicular fluid (PICF).

    Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months

  2. Bacterial DNA Levels

    The reported bacterial assessment values are a mix of the entire bacterial load present in the oral cavity. The values in the data table are a composite measure including Aa, Pg, Pi, Tf, and Td. One composite value is reported for each Arm/Group at each time point.

    Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months

07

Results

Posted Oct 22, 2026

Participant flow

Participant flow — Overall Study
MilestonePeri-mucositis (Air Polishing Group)Peri-mucositis (Ultrasonic Group)Healthy
Started171717
Completed151515
Not completed222
Withdrew: Lost to follow-up222

Outcome measures

PrimaryProbing Depth Measurements

To compare probing depth measurements in millimeters after non-surgical treatment of peri-implant mucositis

Time frame:
Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
Reported as:
Mean · millimeters
Probing Depth Measurements
millimetersPeri-mucositis (Air Polishing Group)Peri-mucositis (Ultrasonic Group)
Baseline3.14 ± 0.163.20 ± 0.14
2 weeks2.91 ± 0.192.97 ± 0.17
4 weeks2.94 ± 0.182.66 ± 0.17
3 months2.87 ± 0.182.94 ± 0.17
6 months3.03 ± 0.183.06 ± 0.17
PrimaryBleeding on Probing Scores (Mombelli et al.)

To compare bleeding on probing after non-surgical treatment of peri-implant mucositis. Possible scores range from 0 to 3, with higher scores indicating heavier bleeding.

Time frame:
Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
Reported as:
Mean · score on a scale
Bleeding on Probing Scores (Mombelli et al.)
score on a scalePeri-mucositis (Air Polishing Group)Peri-mucositis (Ultrasonic Group)
Baseline0.522 ± 0.0560.567 ± 0.062
2 weeks0.357 ± 0.0730.411 ± 0.082
4 weeks0.400 ± 0.0720.323 ± 0.082
3 months0.433 ± 0.0720.411 ± 0.082
6 months0.478 ± 0.0720.533 ± 0.083
PrimaryPlaque Score (Loe & Silness)

To compare plaque scores after non-surgical treatment of peri-implant mucositis. Possible scores range from 0 to 3, with higher scores indicating greater plaque accumulation.

Time frame:
Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
Reported as:
Mean · score on a scale
Plaque Score (Loe & Silness)
score on a scalePeri-mucositis (Air Polishing Group)Peri-mucositis (Ultrasonic Group)
Baseline0.233 ± 0.0870.256 ± 0.054
2 weeks0.186 ± 0.1180.100 ± 0.073
4 weeks0.178 ± 0.1160.023 ± 0.073
3 months0.100 ± 0.1160.067 ± 0.073
6 months0.189 ± 0.1160.142 ± 0.074
PrimaryGingival Index (Loe & Silness)

To compare gingival index scores after non-surgical treatment of peri-implant mucositis. Possible scores range from 0 to 3, with higher scores indicating greater inflammation.

Time frame:
Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
Reported as:
Mean · score on a scale
Gingival Index (Loe & Silness)
score on a scalePeri-mucositis (Air Polishing Group)Peri-mucositis (Ultrasonic Group)
Baseline0.311 ± 0.0430.311 ± 0.059
2 weeks0.143 ± 0.0620.200 ± 0.070
4 weeks0.089 ± 0.0610.189 ± 0.070
3 months0.067 ± 0.0610.089 ± 0.070
6 months0.056 ± 0.0610.015 ± 0.071
PrimaryGum Recession Measurement

To compare gum recession after non-surgical treatment of peri-implant mucositis

Time frame:
Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
Reported as:
Mean · millimeters
Gum Recession Measurement
millimetersPeri-mucositis (Air Polishing Group)Peri-mucositis (Ultrasonic Group)
Baseline0.33 ± 0.130.13 ± 0.066
2 weeks0.25 ± 0.550.13 ± 0.23
4 weeks0.33 ± 0.520.22 ± 0.25
3 months0.13 ± 0.400.17 ± 0.31
6 months0.17 ± 0.410.07 ± 0.18
PrimaryBone Measurement

Loss of supporting bone measured by standardized radiographs

Time frame:
Baseline, 3 months, and 6 months

No measurements were reported for this outcome.

SecondaryInterleukin-6 Levels

To compare changes in the concentration of interleukin-6 (IL-6) in peri-implant crevicular fluid (PICF).

Time frame:
Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
Reported as:
Mean · nanograms per milliliter (Ng/ml)
Interleukin-6 Levels
nanograms per milliliter (Ng/ml)HealthyPeri-mucositis (Air Polishing Group)Peri-mucositis (Ultrasonic Group)
Baseline192.0 ± 220.2335.2 ± 324.5258.5 ± 260.9
2 weeks264.4 ± 277.0419.1 ± 405.1252.2 ± 172.7
4 weeks192.0 ± 183.5343.7 ± 464.1268.6 ± 156.2
3 months187.4 ± 209.6385.5 ± 333.7352.2 ± 247.1
6 months199.4 ± 215.3395.5 ± 424.5300.9 ± 229.8
SecondaryBacterial DNA Levels

The reported bacterial assessment values are a mix of the entire bacterial load present in the oral cavity. The values in the data table are a composite measure including Aa, Pg, Pi, Tf, and Td. One composite value is reported for each Arm/Group at each time point.

Time frame:
Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
Reported as:
Mean · nanograms per microliter (ng/ul)
Bacterial DNA Levels
nanograms per microliter (ng/ul)HealthyPeri-mucositis (Air Polishing Group)Peri-mucositis (Ultrasonic Group)
Baseline12.17 ± 5.4220.33 ± 17.888.67 ± 3.84
2 weeks9.70 ± 5.9319.49 ± 10.6713.54 ± 13.52
4 weeks12.97 ± 10.5216.85 ± 8.117.14 ± 3.38
3 months12.25 ± 8.4316.07 ± 11.9618.40 ± 12.61
6 months7.40 ± 4.3619.21 ± 23.8710.99 ± 12.14

Adverse events

Collected over 6 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Peri-mucositis (Air Polishing Group)0/17 (0%)0/17 (0%)0/17 (0%)
Peri-mucositis (Ultrasonic Group)0/17 (0%)0/17 (0%)0/17 (0%)
Healthy0/17 (0%)0/17 (0%)0/17 (0%)

Baseline characteristics

Age, Customized
Age, Customized(years)HealthyPeri-mucositis (Air Polishing Group)Peri-mucositis (Ultrasonic Group)Total
Mean Age (years)58 ± 1958 ± 1667 ± 1161 ± 15.91
Sex: Female, Male
Sex: Female, Male(Participants)HealthyPeri-mucositis (Air Polishing Group)Peri-mucositis (Ultrasonic Group)Total
Female631120
Male912425
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)HealthyPeri-mucositis (Air Polishing Group)Peri-mucositis (Ultrasonic Group)Total
Count of participants———0
08

Study locations

1 site
  • University of Michigan School of Dentistry
    Ann Arbor, Michigan 48109, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2023 to primary completion in Mar 2025, 16 months.

Results were first posted in Oct 2026, 1 year 7 months after primary completion.

Of 67 non-industry interventional studies with no phase under Mucositis, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 26. This study's 16 months is above that.

Counting every sponsor, half of 70 studies reached it within 12 months; a quarter within 6 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2023
First posted
Nov 18, 2023
StartActual
Oct 31, 2023
Primary completionActual
Mar 19, 2025
CompletionActual
Jun 20, 2025
Results first posted
Oct 22, 2026
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Oct 22, 2026
Enrollment
52→51
Oct 22, 2026
Primary outcomes
6 edited
What changed in the outcomes
  • EditedProbing depth measurementsDepth MeasurementsTime frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
  • EditedBleeding on probing scoresProbing Scores (Mombelli et al.)Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
  • EditedPlaque scoreScore (Loe & Silness)Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
  • EditedGingival indexIndex (Loe & Silness)Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
  • EditedGum recession measurementRecession MeasurementTime frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
  • EditedBone measurementMeasurementTime frame: Baseline, 3 months, and 6 months
Oct 22, 2026
Documents
Secondary outcomes
2 edited
What changed in the outcomes
  • EditedBacterial DNA levelsLevelsTime frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
  • ChangedBefore Inflammatory cytokines levelsNow Interleukin-6 LevelsTime frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    Results posted
    Enrollment 52→51
    Primary outcomes 6 edited
    What changed in the outcomes
    • EditedProbing depth measurementsDepth MeasurementsTime frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
    • EditedBleeding on probing scoresProbing Scores (Mombelli et al.)Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
    • EditedPlaque scoreScore (Loe & Silness)Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
    • EditedGingival indexIndex (Loe & Silness)Time frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
    • EditedGum recession measurementRecession MeasurementTime frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
    • EditedBone measurementMeasurementTime frame: Baseline, 3 months, and 6 months
    Secondary outcomes 2 edited
    What changed in the outcomes
    • EditedBacterial DNA levelsLevelsTime frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
    • ChangedBefore Inflammatory cytokines levelsNow Interleukin-6 LevelsTime frame: Baseline, 2 weeks, 4 weeks, 3 months, and 6 months
    + 3 other changes: verification date, oversight details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT06137846
Responsible party
Hom-Lay Wang, DDS, MSD, Ph D (Collegiate Professor of Periodontics and Professor of Dentistry, University of Michigan) — Principal investigator
First posted
Nov 18, 2023
Start date
Oct 31, 2023
Primary completion
Mar 19, 2025
Completion
Jun 20, 2025
Results posted
Oct 22, 2026
Last update
Oct 22, 2026

Study contacts

Hom-Lay Wang, DDS MSD PhD
principal investigator · Department of Periodontics and Oral Medicine University of Michigan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion